These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9887666)

  • 41. Managing a variable disease.
    Kips J
    Pulm Pharmacol Ther; 2002; 15(6):485-90. PubMed ID: 12493334
    [TBL] [Abstract][Full Text] [Related]  

  • 42. From adrenaline to formoterol: advances in beta-agonist therapy in the treatment of asthma.
    Campbell LM
    Int J Clin Pract; 2002 Dec; 56(10):783-90. PubMed ID: 12510953
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of formoterol dry powder administered for three months via a single-dose inhaler in 1,380 asthmatic patients.
    Clauzel AM; Molimard M; Le Gros V; Lepère E; Febvre N; Michel FB
    J Investig Allergol Clin Immunol; 1998; 8(5):265-70. PubMed ID: 9827420
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Single inhaler budesonide/formoterol in exacerbations of chronic obstructive pulmonary disease.
    Cazzola M
    Pulm Pharmacol Ther; 2006; 19(2):79-89. PubMed ID: 15964228
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adjustable maintenance dosing with budesonide/formoterol in a single inhaler provides effective asthma symptom control at a lower dose than fixed maintenance dosing.
    Canonica GW; Castellani P; Cazzola M; Fabbri LM; Fogliani V; Mangrella M; Moretti A; Paggiaro P; Sanguinetti CM; Vignola AM;
    Pulm Pharmacol Ther; 2004; 17(4):239-47. PubMed ID: 15219269
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lung deposition and efficacy of inhaled formoterol in patients with moderate to severe COPD.
    Derom E; Strandgården K; Schelfhout V; Borgström L; Pauwels R
    Respir Med; 2007 Sep; 101(9):1931-41. PubMed ID: 17544264
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Beta 2 adrenergic agonists--oral or aerosol for the treatment of asthma?
    Kemp JP; Meltzer EO
    J Asthma; 1990; 27(3):149-57. PubMed ID: 1973417
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro testing of two formoterol dry powder inhalers at different flow rates.
    Weuthen T; Roeder S; Brand P; Müllinger B; Scheuch G
    J Aerosol Med; 2002; 15(3):297-303. PubMed ID: 12396417
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Beta agonist therapy: MDI or nebulizer?
    Williams DM
    Am Pharm; 1991 Sep; NS31(9):36, 38. PubMed ID: 1683145
    [No Abstract]   [Full Text] [Related]  

  • 50. Use of a hand-held, metered-dose aerosol delivery device to administer pirbuterol acetate to horses with 'heaves'.
    Derksen FJ; Olszewski M; Robinson NE; Berney C; Lloyd JW; Hakala J; Matson C; Ruth D
    Equine Vet J; 1996 Jul; 28(4):306-10. PubMed ID: 8818596
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Current bronchodilator strategies in the treatment of asthma].
    Aubier M
    Rev Med Interne; 1994; 15 Suppl 2():240s-244s. PubMed ID: 7915852
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-acting asthma medication, new inhaler approved by FDA.
    Thompson CA
    Am J Health Syst Pharm; 2001 Apr; 58(7):557-8. PubMed ID: 11296600
    [No Abstract]   [Full Text] [Related]  

  • 53. Nebulisers for asthma.
    Ward MJ
    Thorax; 1997 Apr; 52 Suppl 2(Suppl 2):S45-8. PubMed ID: 9155850
    [No Abstract]   [Full Text] [Related]  

  • 54. Today's treatment of airway obstruction ... and tomorrow's?
    Flenley DC
    Respiration; 1989; 55 Suppl 2():4-9. PubMed ID: 2572039
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhalation therapy for bronchial asthma: strategies and targets.
    Magnussen H
    Curr Opin Pulm Med; 2003 Apr; 9 Suppl 1():S3-7. PubMed ID: 12974535
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Images in clinical medicine. Airway dilatation after inhalation of a beta-agonist.
    Tamura G; Suda Y
    N Engl J Med; 2005 Apr; 352(15):e14. PubMed ID: 15829529
    [No Abstract]   [Full Text] [Related]  

  • 57. Reversible airway obstruction: neurohumoral mechanisms and treatment. Lecture on asthma: clinical overview.
    Flenley DC
    Respiration; 1986; 50 Suppl 2():57-64. PubMed ID: 2882569
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro aerosol performance and dose uniformity between the Foradile Aerolizer and the Oxis Turbuhaler.
    Asking L; Lundbäck H; Persson B
    J Aerosol Med; 2002; 15(4):435-6; author reply 436-8. PubMed ID: 12581510
    [No Abstract]   [Full Text] [Related]  

  • 59. Floating patterns of metered dose inhalers.
    Wolf BL; Cochran KR
    J Asthma; 1997; 34(5):433-6. PubMed ID: 9350161
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The bronchodilator effect of NAB 365.
    Kamburoff PL; Prime FJ; Schmidt OP
    Br J Clin Pharmacol; 1977 Feb; 4(1):67-71. PubMed ID: 320990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.